EEU - pharmacokinetic equation??? [Power / Sample Size]

posted by mittyri – Russia, 2017-12-29 14:11  – Posting: # 18126
Views: 18,666

Hi Yura,

» So I understand: imagine the power analysis and draw a conclusion (at low power) that since bioequivalence is established, a posteriori power rating does not affect the findings of the study
Yep. Once again: to be lucky is not a crime :-D
and vice versa: if the post-hoc power is -> 100%, you're a hero even if the study was overpowered de facto (i.e. CI [0.98-1.03]).

» More interesting question: the pharmacokinetic equation and its analysis ... :confused:
Good question! Next question!
Seems like they are interested in PK model which is not permitted. No clue so far :-|

Kind regards,
Mittyri

Complete thread:

Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
19,478 posts in 4,133 threads, 1,333 registered users;
online 5 (0 registered, 5 guests [including 5 identified bots]).
Forum time (Europe/Vienna): 20:57 CEST

But it is in matters beyond the limits of mere rule
that the skill of the analyst is evinced.
He makes in silence a host of observations and inferences…    Edgar Allan Poe

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5